SARS-CoV-2 inactivated viral vaccine (Epitopoietic Research)

N/A

Report date: 2025/01/26 16:18:15

Base Information

Drug NameSARS-CoV-2 inactivated viral vaccine (Epitopoietic Research)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapyVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpitopoietic Research Corporation
China Registration ClassN/A

Develop Information

Active CompaniesEpitopoietic Research Corporation
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A